货号:A497963
同义名:
NACA; N-acetyl-L-Cysteine amide
N-acetylcysteine amide是一种能够渗透细胞膜和血脑屏障的硫醇类抗氧化剂和神经保护剂,能够减少活性氧(ROS)的产生。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | N-Acetylcysteine amide had no significant effect on the viability of doxorubicin-treated H9c2 cells at less than 1 mM, but produced significant cytotoxicity at 10-20 mM. N-Acetylcysteine amide at a concentration of 750 μM reduced doxorubicin-induced ROS concentration and lipid peroxidation, and restored the GSH/GSSG ratio and the activities of antioxidant enzymes such as catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR)[1].N-Acetylcysteine amide at a concentration of 1 mM protected human brain microvascular endothelial cells (HBMVEC) from methamphetamine-induced cell death[2]. |
| Concentration | Treated Time | Description | References | |
| HB1.F3.CD neural stem cells | 1 mM | 72 hours | To evaluate the effect of NACA on the viability of CRAd-S-pk7-loaded neural stem cells, the results showed that NACA significantly increased the viability of neural stem cells and enhanced viral replication. | Mol Ther. 2013 Nov;21(11):2063-73. |
| U87 glioma cells | 1 mM | 72 hours | To evaluate the effect of NACA on the viability of U87 glioma cells, the results showed that NACA did not significantly increase the viability of U87 cells. | Mol Ther. 2013 Nov;21(11):2063-73. |
| Human retinal pigment epithelial cells | 1 mM | 8 hours | To evaluate the effect of N-acetylcysteine amide on oxidative stress-induced microparticle release, results showed that NACA significantly reduced oxidative stress-induced microparticle release. | Invest Ophthalmol Vis Sci. 2016 Feb;57(2):360-71. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | VP-PXR transgenic mice | Intraperitoneal injection | 200 mg/kg | Once, 1 hour before HS/R | NACA treatment attenuated HS-induced hepatic injury, as shown by reduced histological necrosis and decreased serum ALT levels. | Hepatology. 2019 Sep;70(3):995-1010 |
| Nude mice | Intracranial glioma xenograft model | Intraperitoneal injection | 250 mg/kg/day | Once daily for 5 days | To evaluate the effect of combined treatment of NACA and CRAd-S-pk7-loaded neural stem cells on the survival of glioma-bearing mice, the results showed that the combined treatment significantly prolonged the survival of mice and increased intratumoral viral distribution. | Mol Ther. 2013 Nov;21(11):2063-73. |
| CD-1 mice | HIV-associated dementia model | Intraperitoneal injection | 250mg/kg | Once daily for 5 days | NACA significantly protected animals from oxidative stress-induced damage and restored BBB permeability | Free Radic Biol Med. 2010 May 15;48(10):1388-98 |
| Drosophila melanogaster | Adult virgin female flies | Oral | 300 µg/mL | 5 hours | NACA treatment improved the movement and survival of larvae exposed to spinosad, indicating a causal role for oxidative stress in the mode of action of spinosad at low doses. | Elife. 2022 Feb 22;11:e73812 |
| Drosophila | Drosophila model | Oral | 40 μg/ml | Starting from 2 days and continued | NACA treatment completely rescued the climbing defects in tau RNAi flies, indicating that aberrant ROS accumulations are driving this phenotype. | Nat Neurosci. 2024 Oct;27(10):1918-1933 |
| Wistar rats | Aβ1-42 peptide-induced Alzheimer's-like pathology model | Intraperitoneal injection | 75 mg/kg | Once daily for 7 days | NACA treatment reversed cognitive deficits and reduced oxidative stress in the hippocampus and prefrontal cortex. Western blot analysis and immunohistochemistry demonstrated NACA's neuroprotective effects on neurogenesis, expression of neurofibrillary tangles, β-amyloid peptide, synaptophysin, neuronal morphology, and gliosis. | Int J Mol Sci. 2023 Aug 12;24(16):12733 |
| Drosophila melanogaster | Drosophila larvae and adults | Supplemented in food | 75 μg/mL | Continuous administration for 20 days | NACA significantly ameliorated the accumulation of LDs in the fat body, impaired larval movement and adult climbing ability, and reduced adult longevity caused by imidacloprid. | Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25840-25850 |
| Animal study | N-Acetylcysteine amide increases bioavailability in the central nervous system. Administered intraperitoneally at a dose of 150 mg/kg, N-Acetylcysteine amide improves cortical laxity and functional recovery, reduces oxidative stress, improves mitochondrial bioenergetics, and maintains mitochondrial glutathione levels after traumatic brain injury (TBI) in rats[3]. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
6.16mL 1.23mL 0.62mL |
30.82mL 6.16mL 3.08mL |
61.65mL 12.33mL 6.16mL |
|
| CAS号 | 38520-57-9 |
| 分子式 | C5H10N2O2S |
| 分子量 | 162.21 |
| SMILES Code | O=C(N)[C@@H](NC(C)=O)CS |
| MDL No. | MFCD01696115 |
| 别名 | NACA; N-acetyl-L-Cysteine amide; Nac amide |
| 运输 | 蓝冰 |
| InChI Key | UJCHIZDEQZMODR-BYPYZUCNSA-N |
| Pubchem ID | 10176265 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(647.31 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 200 mg/mL(1232.97 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1